Melissa Maisenbacher

Patients' experiences using an educational virtual assistant for review of reproductive genetic screening results

Sarah Yarnall, Jessica L. Saben, Melissa Maisenbacher, Talia Shirazi et autres

This observational study aimed to capture patients' experiences after reviewing carrier screening (CS) and/or noninvasive prenatal cell-free DNA testing (NIPT) results with Natera's Educational Virtual Assistant (NEVA). Patients, partners of patients, or other individuals designated to review the patients' results were included …

us (code pays fourni par la source)

Response: Would surgical retrieval of product of conception for the purpose of genetic analysis increase the risk of intra uterine adhesions?

William H. Kutteh, Melissa Maisenbacher, Elias M. Dahdouh

us, ca (code pays fourni par la source)

Role of Genetic Analysis of Products of Conception and PGT in Managing Early Pregnancy Loss

William H. Kutteh, Ralph S. Papas, Melissa Maisenbacher, Elias M. Dahdouh

(Abstracted from Reprod Biomed Online 2023;49(1):103738) Recurrent pregnancy loss (RPL), defined by 2 or more failed clinical pregnancies before 20 weeks’ gestation, affects 2% to 4% of reproductive-aged women worldwide. The recommended workup for RPL includes karyotypes in both partners, imaging of …

us, lb, ca (code pays fourni par la source)

910 Performance of SNP-based cell-free DNA prenatal screening for 22q11.2 deletion syndrome in a commercial population

Wendy DiNonno, Melissa Maisenbacher, Georgina Goldring, Melda Balcioglu et autres

Role of genetic analysis of products of conception and PGT in managing early pregnancy loss

William H. Kutteh, Ralph S. Papas, Melissa Maisenbacher, Elias M. Dahdouh

This article considers the addition of comprehensive 24-chromosomal microarray (CMA) analysis of products of conception (POC) to a standard evaluation for recurrent pregnancy loss (RPL) to help direct treatment towards expectant management versus IVF with preimplantation genetic testing for aneuploidies (PGT-A). The …

us, lb, ca (code pays fourni par la source)

Hereditary cancer testing in a diverse sample across three breast imaging centers

Laura Westbrook, Darlene M. Miltenburg, Vivienne Souter, Melissa Maisenbacher et autres

PURPOSE: Up to 10% of all breast cancers (BC) are attributed to inherited pathogenic variants (PV) in BC susceptibility genes; however, most carriers of PVs remain unidentified. Here, we sought to determine the yield of hereditary cancer gene PVs among diverse women …

us (code pays fourni par la source)

INVESTIGATING THE INCIDENCE OF THE 22q11.2 DELETION SYNDROME IN MISCARRIAGE

Melissa Maisenbacher, Katrina Merrion, Karine Hovanes, Jeffrey T. Meltzer et autres

us (code pays fourni par la source)

Maternal Sex Chromosome Aneuploidy Identified through Noninvasive Prenatal Screening: Clinical Profile and Patient Experience

Aaron W. Roberts, Melissa Maisenbacher, Sheetal Parmar, J. Wilkinson et autres

OBJECTIVE: Noninvasive prenatal screening (NIPS) may incidentally identify maternal aneuploidies that have health implications. We evaluated patients' experience with counseling and follow-up diagnostic testing after NIPS flags a potential maternal sex chromosome aneuploidy (SCA). STUDY DESIGN: Patients who underwent NIPS at two …

us (code pays fourni par la source)

Undetected Maternal Cell Contamination in Products of Conception Analysis May Mask Recurrence Risks for Future Pregnancies: A Case Report and Discussion [ID: 1377203]

Katrina Merrion, Lindsey Campbell, Karine Hovanes, Russel D. Jelsema et autres

INTRODUCTION: Maternal cell contamination (MCC) in products of conception (POC) tissue is common; some studies report 59% of 46,XX results represent MCC. METHODS: Products of conception tissue and maternal blood samples were shipped to a laboratory for genotyping using Illumina CytoSNP-12b microarrays …

us (code pays fourni par la source)

Abstract P6-02-06: Implementation and outcomes of population-based hereditary cancer testing across a diverse multi-location breast imaging center

Darlene M. Miltenburg, Laura Westbrook, Vivienne Souter, Melissa Maisenbacher et autres

Abstract Introduction: Up to 10% of all breast cancers (BC) are attributed to inherited pathogenic variants (PV) in BC susceptibility genes, and genetic testing at the time of breast imaging may identify more patients who could benefit from enhanced surveillance and/or risk …

us (code pays fourni par la source)

Maternal sex chromosome aneuploidy identified through noninvasive prenatal screening: clinical profile and patient experience

Aaron W. Roberts, Melissa Maisenbacher, Sheetal Parmar, J. Wilkinson et autres

Concordance rates of SNP-NIPT and SNP-array products of conception analysis from a single laboratory

Melissa Maisenbacher, Katrina Merrion, Wendy DiNonno, Amanda M. Shrewsbury et autres

us (code pays fourni par la source)